Prevention of mumps


Mitigation prophylaxis

Epidemic parotitis refers to viral infectious diseases, it is accompanied by intoxication of the body and inflammation of the salivary glands. In more rare cases, other glands of the body, some internal organs or the nervous system suffer from mumps.

Disease of any form and severity may pose a threat to surrounding healthy people. The danger of infection occurs 1-2 days before the first clinical manifestations of mumps, after the ninth day of illness the patient is no longer considered infectious.

Transmission of the virus occurs by airborne droplets, with rare exceptions, parotitis can be transmitted from the mother to the fetus (intrauterine infection).

Patients with mumps should be isolated in the first nine days after the onset of the disease. On the 21st day after the contact, quarantine is declared.

Children under 10 years old who have not previously mumps and do not have immunity are exposed to the prevention of isolation. Ten days after contact with the sick, doctors begin to systematically examine children to identify parotitis in their early stages if they become infected.

Vaccination against mumps

In order to prevent mumps, active immunization with live mumps vaccine is being conducted today. Vaccination against mumps is considered very effective from the immunological and epidemiological point of view.

The vaccine is administered to children aged one year. One dose is placed once under the skin. In six years it is necessary to conduct a booster.

Children who were in contact with a sick person are injected unscheduled. Such vaccination is carried out urgently and is put only to those who have not previously had mumps and have not been vaccinated. / h vaccine against mumps

There are currently five vaccines registered in the Russian Federation that are used to prevent mumps. This is a monovaccine, a divac vaccine (parotite, measles) and three trivaccines directed against mumps, measles and rubella.

Different strains of viruses are used in different countries to produce vaccine against mumps. In Russia, strain L3 is used for these purposes.

In our country, the monovalent vaccination has been carried out since 1981. At the beginning of the XXI century on the territory of the Russian Federation began the production of domestic diabetic vaccine. Its use is currently preferred as the most economically viable and relevant ethical issues in the field of vaccine prophylaxis to the drug. The digoxin is characterized by a sufficient amount of immunogenicity, and its reactogenicity is no different from a monovalent.

The domestic pharmaceutical industry does not produce trivaccines. Foreign vaccines, which are used to prevent mumps, measles and rubella, differ from each other in strains of pathogens. All of them have practically identical immunobiological properties and are allowed to be used for vaccine prevention in accordance with the Russian vaccination calendar.


Please enter your comment!
Please enter your name here